Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 2 of the last 4 fiscal years.
-
Busy address KBO
18 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
INlabs from Wommelgem, company number BE0767488447, closed financial year 2025 with a result of € -99,945 after tax. For that financial year INlabs recorded a gross margin of € -62,524 and equity of € -118,351. Compared with financial year 2024, the result moved from € 83,154 to € -99,945. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 3, 2026.
€ -118,351
▼ € 139,598 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -99,945
▼ still € 83,154 profit in 2024
Profit after tax over the fiscal year.
€ 762
▼ 97% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -204,849.
Debts at end 2025
€ 225,085
▲ 23% vs 2024
Loans from banks and other lenders, long and short.
€ 2,015
▼ 91% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 49,082 | € -28,667 | € 100,446 | € -62,524 | ▼ € 162,970 |
| Profit after taxes | € -1,396 | € -59,268 | € 83,154 | € -99,945 | ▼ € 183,099 |
| Equity | € 36,306 | € -22,254 | € 21,247 | € -118,351 | ▼ € 139,598 |
| Total debts | € 527,813 | € 298,145 | € 245,177 | € 228,232 | ▼ 7% |
| Cash | € 54,856 | € 116 | € 24,234 | € 762 | ▼ 97% |
| Retained profit | € -128,790 | € -188,058 | € -104,904 | € -204,849 | ▼ € 99,945 |
| Bank debt | € 302,000 | € 218,400 | € 183,000 | € 225,085 | ▲ 23% |
| Balance sheet total | € 609,151 | € 321,159 | € 298,474 | € 128,714 | ▼ 57% |
Key figures of INlabs, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to INlabs?
What happened at INlabs in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 99,945 (▼ € 183,099 vs 2024). Source: NBB ↗
- 2XU Group BV became a director. NBB
- XANDER DENYS became a director. NBB
- DIETER BRACKE became a director. NBB
- New establishment in Wommelgem. KBO
- Start of the company according to the CBE. KBO
In short
From € 1,396 loss in 2022 to € 99,945 loss in 2025.
Best year ever: 2024, with € 83,154 profit.
A new publication or filing at INlabs? We notify you, reason included.
Follow INlabsDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Samband Guis Mitiah Europe comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
INlabsBehind INlabs are XANDER DENYS, 2XU Group BV and DIETER BRACKE. The shares are held by Samband Guis Mitiah Europe (20%).
Directors
According to the 2025 annual accounts
since 2025
Director · represented by Van Noten Johan
Also active at: SIVAC, J. & F. DE LAET, INTELLIGENT NUTRITION, DILITO, STIMMER, ELP, Transformics, CONCEPTZ +4 more
since 2026
DIETER BRACKE
Director
since 2025
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Draaiboomstraat 6 box 14
2160 Wommelgem
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 18 companies are registered at this address.
All companies at this address →SIVAC same network
€ 34 million revenue · 2025
J. & F. DE LAET same network
€ 275,691 gross margin · 2025
INTELLIGENT NUTRITION same network
€ -1,526 gross margin · 2025
DILITO same network
€ 17 million revenue · 2025
BETTINA SCHWARZ
€ -105,864 gross margin · 2025
+13 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0767.488.447
- VAT number
- BE 0767.488.447
- Registered office
- Draaiboomstraat 6 bus 14, 2160 Wommelgem
- Names & denominations
- INlabs
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 26 April 2021
- Peppol
- Active · Active since 31 Oct 2023
- Activities · NACE
Handelsbemiddeling in de groothandel in voedings- en genotmiddelen
Overige niet-gespecialiseerde detailhandel
Groothandel in andere voedingsmiddelen, neg
Detailhandel via postorderbedrijven of via internet